Baring Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$524K Buy
453
+54
+14% +$63.7K 0.28% 55
2026
Q2
$479K Sell
399
-11
-3% -$11.2K 0.26% 56
2026
Q1
$377K Buy
410
+24
+6% +$24.3K 0.23% 59
2025
Q4
$415K Buy
386
+102
+36% +$97.5K 0.25% 56
2025
Q3
$217K Buy
284
+2
+0.7% +$1.49K 0.15% 66
2025
Q2
$220K Sell
282
-17
-6% -$13.2K 0.16% 64
2025
Q1
$247K Buy
299
+29
+11% +$24.1K 0.21% 57
2024
Q4
$208K Buy
+270
New +$224K 0.19% 62

Other funds holding LLY

Baring Financial's LLY Position: Q3 2026 in Review

Baring Financial increased its Eli Lilly (LLY) stake by 14% in Q3 2026, buying an estimated $63.7K and bringing the position to 453 shares worth $524K. The position accounts for 0.28% of the portfolio, ranked #55.

Baring Financial first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Baring Financial held 453 shares of Eli Lilly worth $524K as of Q3 2026.
  • Baring Financial bought 54 Eli Lilly shares in Q3 2026, an estimated $63.7K.
  • Eli Lilly made up 0.28% of Baring Financial's portfolio in Q3 2026, its #55 holding.
  • Baring Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Baring Financial's 13F filing for Q3 2026, filed 7 Oct 2026.